Yahoo奇摩 網頁搜尋

登入

搜尋結果

  1. www.covid19-druginteractions.orgLiverpool COVID-19 Interactions

    Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and researchers.

  2. www.covid19-druginteractions.org › checkerLiverpool COVID-19 Interactions

    Drug Interactions. Check COVID/COVID drug interactions. Drug combinations may have been assessed either by study or within the product label, or an interaction may have been predicted based on the metabolic profiles of the drugs.

  3. www.covid19-druginteractions.org › prescribing_resourcesLiverpool COVID-19 Interactions

    A summary of interactions with COVID-19 antiviral therapies (licensed or under clinical investigation) and over 1000 comedications are given in this PDF. At-a-glance summary of interactions with COVID-19 host-directed therapies

  4. www.covid19-druginteractions.org › view_all_interactionsLiverpool COVID-19 Interactions

    Please make a selection of Covid drugs below to build a table of interactions showing all comedications. Copyright © 2024 The University of Liverpool. All rights reserved. Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and researchers.

  5. www.covid19-druginteractions.org › aboutLiverpool COVID-19 Interactions

    In order to address this, the Liverpool Drug Interactions website team developed this freely available drug interactions resource to provide information on the likelihood of interactions between the experimental agents used for the treatment of COVID-19 and

  6. www.covid19-druginteractions.org › interactions › 20296Liverpool COVID-19 Interactions

    Of interest, no adverse outcomes were reported in six HIV infected patients treated with a reduced dose of apixaban (2.5 mg twice daily) while on ritonavir boosted regimens suggesting that a reduced dose of apixaban could be used with nirmatrelvir/ritonavir.

  7. www.covid19-druginteractions.org › committeeLiverpool COVID-19 Interactions

    The Programme Steering Committee (PSC) provides independent expert oversight of the Liverpool Drug Interactions programme, including the web- and app-based prescribing tools for managing drug-drug interactions for HIV, hepatitis and COVID-19.

  8. www.covid19-druginteractions.org › site_news › 123Liverpool COVID-19 Interactions

    2023年11月27日 · Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and researchers.

  9. www.covid19-druginteractions.org › interactions › 20316Liverpool COVID-19 Interactions

    Coadministration is contraindicated. Decreased plasma concentrations of nirmatrelvir/ritonavir may lead to loss of virologic response and possible resistance. Carbamazepine is strong CYP3A4 inducer, and this may lead to a decreased exposure of nirmatrelvir and ritonavir and potential loss of virologic response.

  10. covid19-druginteractions.org › interactions › 22574Liverpool COVID-19 Interactions

    Comprehensive, up-to-date, evidence-based COVID19 drug-drug interaction resource, freely available to healthcare workers, patients and researchers.